Viscogliosi Brothers

Stryker - Spinal Implants Business is a unit of Stryker.

Companion Spine specializes in interventional therapies and technologies for back pain resolution. Their approach aims to minimize disruption, reduce pain, and enhance safety, thereby improving patients' quality of life.

Spine BioPharma develops non-surgical therapies for back pain and degenerative spine diseases, aiming to reduce pain, restore function, and slow or stop disease progression. Its lead candidate targets degenerative disc disease, seeking clinical benefits of pain relief, functional restoration, and potential prevention of disease progression, enabling individuals with chronic spine conditions to improve their quality of life. The company emphasizes opioid-free, safe and effective therapies that address pain and inflammation.

Spine BioPharma develops non-surgical therapies for back pain and degenerative spine diseases, aiming to reduce pain, restore function, and slow or stop disease progression. Its lead candidate targets degenerative disc disease, seeking clinical benefits of pain relief, functional restoration, and potential prevention of disease progression, enabling individuals with chronic spine conditions to improve their quality of life. The company emphasizes opioid-free, safe and effective therapies that address pain and inflammation.

Companion Spine specializes in interventional therapies and technologies for back pain resolution. Their approach aims to minimize disruption, reduce pain, and enhance safety, thereby improving patients' quality of life.

Spine BioPharma develops non-surgical therapies for back pain and degenerative spine diseases, aiming to reduce pain, restore function, and slow or stop disease progression. Its lead candidate targets degenerative disc disease, seeking clinical benefits of pain relief, functional restoration, and potential prevention of disease progression, enabling individuals with chronic spine conditions to improve their quality of life. The company emphasizes opioid-free, safe and effective therapies that address pain and inflammation.

Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

Small Bone Innovations (SBi) is a medical device company specializing in the design, manufacture, and distribution of implants tailored for small bones and joints. Their product portfolio focuses on trauma and arthroplasty applications, catering specifically to the thumb, hand, wrist, elbow, foot, and ankle regions. SBi's offerings include basal joint arthritis treatments and implants designed to replace anatomic joint surfaces while preserving bones and minimizing disruption to collateral ligaments and soft tissues.

Spine Next is a France-based biotech company established in 1999, specializing in the manufacture and marketing of orthopedic spinal implant devices designed for spinal fusion surgeries. The company is known for its Wallis system, a stabilization device that addresses degenerative disc disease without the need for vertebral fusion. In 2004, Spine Next was acquired by Abbott, further enhancing its capabilities in the orthopedic market.

Raymedica, Inc. is an emerging medical device manufacturer based in Minneapolis, Minnesota, focused on developing innovative solutions for surgical treatment of low back pain in patients who have not responded to conservative care. The company aims to enhance the quality of life for these patients worldwide by advancing the technology created by its founder, Charles D. Ray, M.D. Raymedica is currently concentrating its efforts on the PDN® prosthetic disc nucleus, designed specifically for treating low back pain associated with degenerative disc disease. This device is surgically implanted into the evacuated nucleus disc space of the lumbar spine, with the intention of increasing or maintaining disc height and restoring normal biomechanics, ultimately alleviating pain.